Dov Goldstein – Biography
Last update: January 19, 2026Executive profile
Dov was Chief Financial Officer and Chief Business Offer at Indapta Therapeutics, and Director at NeuBase Therapeutics.
Dov Goldstein is currentlyChief Financial Officer at BioAge - View - BioAge org chart
Director at Coya Therapeutics - View - Coya Therapeutics org chart
Independent Member at Gain Therapeutics - View - Gain Therapeutics org chart
Create your alert
to follow the career of Dov Goldstein.
Education
Dov Goldstein has a Doctor of Medicine from Yale University - School of Medicine in 1995 and a Master of Business Administration in Finance from Columbia University - Business School in 1998.
They have also studied at Yale University - School of Medicine :
Find more alumni from Yale University - School of Medicine
They have also studied at Columbia University - Business School :
Find more alumni from Columbia University - Business School
More about Dov Goldstein
Selected links
Do you need to know more about Dov Goldstein? More results.
Participate
Social media
- Dov Goldstein on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Dov Goldstein
The colleagues of Dov Goldstein
Company Colleagues
- At BioAge, Dov Goldstein has 18 colleagues including Kristen Fortney (CEO & Director), Patrick Enright (Director)…
- At Coya Therapeutics, Dov Goldstein has 13 colleagues including Arun Swaminathan (CEO & Director), Wilbur Ross (Director)…
- At Gain Therapeutics, Dov Goldstein has 21 colleagues including Gene Mack (CEO & President), Eric Richman (Director)…
Industry Colleagues
- In the Biotechnology industry, Dov Goldstein has 35,762 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Dov Goldstein.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Dov Goldstein.
